Ojai Goliad

Total investments

2

Average round size

7M

Portfolio companies

1

Lead investments

1

Follow on index

0.50

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyPharmaceuticalBiopharma

Summary

The company was established in North America in United States. The main office of represented VC is situated in the Dallas.

The important activity for fund was in 2004. The increased amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are The University of Texas at Austin, Startech Early Ventures, Cardinal Investment Co.. In the next rounds fund is usually obtained by Novo Holdings, CPMG.

Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Reata Pharmaceuticals.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
1
Exits
1
Follow on index
0.50
Investments by industry
  • Biotechnology (2)
  • Pharmaceutical (2)
  • Biopharma (2)
Investments by region
  • United States (2)
Peak activity year
2004
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Group Appearance index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Reata Pharmaceuticals 12 Nov 2004 Biotechnology, Pharmaceutical, Biopharma Late Stage Venture 12M United States, Texas, Irving

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.